Nirsevimab
Administration of nirsevimab (Beyfortus) for eligible infants and toddlers starts October 1, 2025.
The administration of maternal Abrysvo (given between 32–36 weeks of pregnancy) will continue year-round in the YK delta region.
The 50mg dose can be found in the OB pyxis, the OPC fridges have a supply of 50mg and 100mg, and village clinics and SRCs are in the process of being stocked.
If you have a specific patient in need of nirsevimab, or any questions at all, don’t hesitate to reach out to Kristina Morris, or the immunizations department, to assist. Keep in mind, Vactrak will NOT forecast correctly, especially 2nd season doses.
There is no projected shortage this 2025-2026 season and we aim to immunize as many as possible, as early in the season as possible. As of October 1, 2025, the YK delta has NOT yet seen RSV circulating in the waste water or a lab positive case of RSV.
Resources
Nirsevimab (RSV Antibody) 2025-2026 Season [Alaska Department of Health Respiratory Virus Snapshot]
State of AK Epi Bulletin, RSV immunization guidance for the 2025-2026 season- RSV 2025-26 Season
